Sanctuary Advisors LLC Takes $104,000 Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Sanctuary Advisors LLC bought a new stake in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 10,167 shares of the company’s stock, valued at approximately $104,000. Sanctuary Advisors LLC owned 0.15% of Global X Genomics & Biotechnology ETF as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Atria Investments Inc acquired a new position in Global X Genomics & Biotechnology ETF during the third quarter worth about $122,000. Rockefeller Capital Management L.P. acquired a new position in Global X Genomics & Biotechnology ETF during the third quarter worth about $205,000. Oxinas Partners Wealth Management LLC acquired a new position in Global X Genomics & Biotechnology ETF during the fourth quarter worth about $103,000. Insight Advisors LLC PA boosted its position in Global X Genomics & Biotechnology ETF by 20.4% during the fourth quarter. Insight Advisors LLC PA now owns 29,192 shares of the company’s stock worth $282,000 after acquiring an additional 4,942 shares during the last quarter. Finally, McGuire Investment Group LLC boosted its position in Global X Genomics & Biotechnology ETF by 3.5% during the fourth quarter. McGuire Investment Group LLC now owns 58,109 shares of the company’s stock worth $564,000 after acquiring an additional 1,940 shares during the last quarter. Institutional investors and hedge funds own 56.95% of the company’s stock.

Global X Genomics & Biotechnology ETF Trading Down 0.4 %

GNOM opened at $9.07 on Friday. The firm has a market capitalization of $60.68 million, a PE ratio of -3.88 and a beta of 1.17. Global X Genomics & Biotechnology ETF has a twelve month low of $8.64 and a twelve month high of $12.20. The firm’s 50-day moving average price is $9.82 and its 200 day moving average price is $10.44.

Global X Genomics & Biotechnology ETF Profile

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.